HOMB:NYSEHome BancShares, Inc. Analysis
Data as of 2026-08-01 - not real-time
$31.07
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Home BancShares (HOMB) is trading comfortably above its short‑term moving averages, with momentum indicators showing a bullish bias and the RSI climbing toward the upper range. The stock’s price‑to‑earnings multiple sits well below the regional banking peer average, while the dividend yield remains attractive and the payout ratio is comfortably low, underscoring cash‑flow strength. Recent earnings releases highlighted a record net income driven by loan growth and strategic acquisitions, and the board announced a modest increase in the quarterly cash dividend, reinforcing the income component of the investment.
From a risk perspective, the share exhibits low beta and moderate volatility, and the decreasing volume trend suggests a gradual shift in market participation rather than acute liquidity stress. Combined with a solid capital base, low leverage, and a diversified geographic footprint across several states, the risk profile remains manageable, supporting a positive outlook across short‑ to long‑term horizons.
From a risk perspective, the share exhibits low beta and moderate volatility, and the decreasing volume trend suggests a gradual shift in market participation rather than acute liquidity stress. Combined with a solid capital base, low leverage, and a diversified geographic footprint across several states, the risk profile remains manageable, supporting a positive outlook across short‑ to long‑term horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Bullish technical alignment above key moving averages
- Recent dividend increase enhancing yield appeal
- Strong earnings beat with loan growth
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable valuation relative to peers
- Consistent profitability and modest leverage
- Potential headwinds from regional banking regulatory environment
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable business model with diversified loan portfolio
- Attractive dividend yield and sustainable payout
- Undervalued pricing offering margin of safety
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin43.65%
P/E Ratio12.9
ROE11.11%
ROA2.01%
P/B Ratio1.4
Industry P/E18.0
Technical Analysis
TrendBullish
RSI67.4
Support$28.07
Resistance$31.70
MA 20$30.05
MA 50$28.55
MA 200$27.92
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Target Price$33.00
Upside/Downside6.21%
GradeUndervalued
TypeValue
Dividend Yield2.76%
Risk Assessment
Beta0.45
Volatility20.57%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.